Cyclo Therapeutics, Inc.

CYTHCIK 0000922247 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Dec 18, 2024. Sentiment + YoY language diff vs prior year. Read sections →

Signal:Neutral

Risk Factors: not detected

MD&A: not detected

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Mar 26, 2025no items parsed Mar 24, 20255.07 · Submission Mar 6, 2025no items parsed Feb 4, 2025no items parsed Jan 13, 2025no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Cyclo Therapeutics, Inc.

Name	Roles	Filings
Fine Joshua M	Officer	3
Lisjak Michael Eric	Officer	3
Rafael Holdings, Inc.	10% Owner	3
Kjems Lise Lund	Officer	2

Showing 11-14 of 14

Per pagePrevPage 3 of 3

All filings

107 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Mar 3, 2025	Sieger Markus Director	AGrant	58,138	$0.00	$0
Mar 3, 2025	Ostronic Francis Patrick Director	AGrant	70,329	$0.00	$0
Mar 3, 2025	Strattan Ce Rick Director	AGrant	30,169	$0.00	$0
Mar 3, 2025	Toig Randall M. Director	AGrant	33,311	$0.00	$0
Mar 3, 2025	Cross Shawn Director	AGrant	28,597	$0.00	$0

Showing 1-5 of 107

Per pagePage 1 of 22Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value